# Biocryst Pharmaceuticals Inc: Form 8-K/A, filed Aug 4, 2026

- Company: [Biocryst Pharmaceuticals Inc](/companies/bcrx.md) (CIK 882796)
- Form: 8-K/A
- Filed: 2026-08-04
- Accepted by EDGAR: Aug 4, 2026, 07:01 ET
- Period: 2026-06-25
- Accession: 0001171843-26-005168
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/882796/000117184326005168/f8ka_080326.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/882796/000117184326005168/

## Items reported

- Item 2.05: Exit or disposal costs

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/882796/000117184326005168/f8ka_080326.htm

Filed Aug 4, 2026.
Source: SEC EDGAR, the filing index for accession 0001171843-26-005168. Last ingested by Listed: Nov 4, 2026, 16:44 ET. No prices; not investment advice.